Dosing and Administration

ERLEADA™ offers once-daily oral dosing1

Tablets shown are not actual size.

The recommended dose of ERLEADA™ is 240 mg (four 60 mg tablets) administered  orally once daily 1

Patients should also receive a GnRH analog concurrently or should have had a bilateral orchiectomy.1

No additional laboratory monitoring requirements beyond routine assessments for side effects.1

Can be taken with or without food. Tablets should be swallowed whole.1

No initial dose adjustments for ERLEADA™ are necessary for renal or hepatic impairment.1

Dose Modifications

If a patient experiences a ≥Grade 3 toxicity or an intolerable side effect, hold dosing until symptoms improve to ≤Grade 1 or original grade, and then resume at the same dose or a reduced dose (180 mg or 120 mg), if warranted.1

GnRH = gonadotropin-releasing hormone.

Reference

1. ERLEADA™ [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.